articles
- Antibody responses to immunization with HCV envelope glycoproteins as a baseline for B-cell-based vaccine development. 158:1058-1071. 2020
- Is elimination of hepatitis B and C a pipe dream or reality?. 156:294-296. 2019
- Nuclear receptor subfamily 1 group D member 1 regulates circadian activity of NLRP3 inflammasome to reduce the severity of fulminant hepatitis in mice. 154:1449-1464. 2018
- Effectiveness of ledipasvir-sofosbuvir combination in patients with hepatitis C virus infection and factors associated with sustained virologic response. 151:1131-1140. 2016
- Mitochondrial amino acid metabolism provides vulnerabilities in mutant KRAS-driven cancers. 151:798-801. 2016
- Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen production. 148:403-414. 2015
- Isolation and characterization of intestinal stem cells based on surface marker combinations and colony-formation assay. 145:383-395.e21. 2013
- Bariatric surgery in the era of personalized medicine. 144:497-500. 2013
- Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice. 144:808-817. 2013
- Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. 138:1338-1345. 2010
- Distinct effects of p38alpha deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease. 138:1255-1265. 2010
- Lysophosphatidic acid stimulates the intestinal brush border NA(+)/H(+) exchanger 3 and fluid absorption via LPA(5) and NHERF. 138:649-658. 2010
- Heritability of nonalcoholic fatty liver disease. 136:1585-1592. 2009
- The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. 136:1711-1720. 2009
- Identification of epcam as the gene for congenital tufting enteropathy. 135:429-437. 2008
- Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. 121:131-139. 2001
- Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease. 116:593-601. 1999
- Antisense RNA complementary to hepatitis B virus specifically inhibits viral replication. 115:702-713. 1998
- Adenoviral vectors given intravenously to immunocompromised mice yield stable transduction of the colonic epithelium. 112:1586-1594. 1997
- Oncogene alterations in primary human-colon tumors. 91:1503-1510. 1986
- Tularemic hepatitis presenting as obstructive-jaundice. 91:461-463. 1986
- Liver-specific protein in perspective. 78:168-170. 1980
- Reversibility of hepatitis B virus-induced glomerulonephritis and chronic active hepatitis after spontaneous clearance of serum hepatitis B surface antigen. 75:1152-1156. 1978